Cathy Eng, MD, FACP, FASCO, joined a panel of experts at the White House Cancer Moonshot Colorectal Cancer Forum in highlighting the need for greater patient participation in and funding for cancer clinical trials.Eng, the David H. Johnson professor of surgical and medical oncology at Vanderbilt University, described the panel discussion last month as very productive. Other participants
Sleep disorders are among the biggest issues patients with cancer and survivors face, yet research on interventions to address these disorders remains sparse, according to speakers at National Comprehensive Cancer Network Annual Conference.“A study out of Finland published about 2 years ago looked at a group of survivors and compared them [with] age-matched individuals without cancer in the
Researchers have begun enrolling patients in Pragmatica-Lung, an NCI-supported phase 3 study designed specifically to eliminate barriers to clinical trial accessibility and participation.The trial, also known as S2302, will evaluate a two-drug combination for patients with advanced non-small cell lung cancer. It will be among the first NCI-supported trials to use a pragmatic trial design aimed at
It’s not often that a 2 a.m. phone call marks the highlight of someone’s career.“It woke me up, and I looked at the phone and saw the call was from Sweden,” Carolyn R. Bertozzi, PhD, told Healio. “It was a shocking, surreal experience to receive that phone call.’’
Precision medicine has shown great potential to improve treatment outcomes and prolong survival of patients with lung cancer, as biomarker-driven therapies continue to extend their reach in this space.According to International Association for the Study of Lung Cancer, more than half of patients with lung cancer have tumors that harbor potentially actionable driver mutations. Therapies targeting